|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/127 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| C12N 15/86 | (2006.01) |
| (11) | Number of the document | 2590626 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11736500.7 |
| Date of filing the European patent application | 2011-07-06 | |
| (97) | Date of publication of the European application | 2013-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-28 |
| (46) | Date of publication of the claims translation | 2016-01-25 |
| (86) | Number | PCT/US2011/043105 |
| Date | 2011-07-06 |
| (87) | Number | WO 2012/006378 |
| Date | 2012-01-12 |
| (30) | Number | Date | Country code |
| 361830 P | 2010-07-06 | US | |
| 378837 P | 2010-08-31 | US |
| (72) |
GEALL, Andrew, US
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Liposomos su lipidais, turinčiais palankią pKa-reikšmę RNR įvedimui |
| LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 15 | 289.00 EUR |
| 2026-07-06 |